A class of disease that affects the lungs and other parts of the respiratory system. Currently, World Health Organisation estimates indicate that 235 million people worldwide suffer with asthma, 64 million with chronic obstructive pulmonary disease (COPD) and millions with allergic rhinitis. These respiratory diseases put a huge burden on individuals and society as the unmet medical need is substantial, with patients often remaining symptomatic for many years despite using the best available therapies. CD BioSciences offers extensive global experience in program consultancy and multi-service studies, along with full-service clinical development program ownership. Our experts are committed to anticipating and overcoming the challenges of your drug development pipeline.
Experience Based on Expertise
At CD BioSciences, our medical experts understand that the commercial viability of therapeutics for chronic respiratory disorders is influenced by a range of factors, including perceived value and therapeutic novelty. This has particular relevance to illnesses with established pharmacotherapy such as asthma and COPD. Our dedicated respiratory disease expert group and clinical operations team have years of experience working on respiratory studies with global coverage. Our expert teams have extensive therapeutic and regulatory experience across the broad spectrum of indications shown in the right side.
Compelling Offering on Expertise
CD BioSciences clinical trials provides multiple services, including clinical monitoring or project management services across all phases. Moreover, we offer seamless end-to-end in-house clinical research services. CD BioSciences experts will develop customized solutions to support your development programs and ensure timely and quality delivery. Thanks to our experienced professionals, we provide several services for clients, including:
Grounded in medicine and science, CD BioSciences enables sponsors to move from medical discovery into clinical development and commercialization, helping bring innovative solutions to market that deliver enhanced value and improve patient lives. CD BioSciences provides therapeutic solutions for our custom, which is data management analysis and reporting, proof of concept (POC), early phase trials, first in human, phase IIa trials, and phase III trials.
The core of a successful working relationship and part of our customer excellence approach with our clients is being flexible to their requirements. Therefore, CD BioSciences will work with our partner customers to define specific requirements and expectations to meet the partnership objectives. CD BioSciences aspires to become the trusted solution provider of your first choice. Our advanced technologies and highly experienced staffs are committed to advancing your program and reducing the overall development timeline. For further details, please don't hesitate to contact us.